Erratum: A novel stop mutation in the vascular endothelial growth factor-C gene (VEGFC) results in Milroy-like disease [J Med Genet 51, (2014) 475?478] DOI:10.1136/jmedgenet-2013-102020;A novel stop mutation in the vascular endothelial growth factor-C gene (VEGFC) results in Milroy-like disease

Journal of Medical Genetics

Volumn 51, Issue 7, 2014, Pages 475-478

  Balboa Beltran, Emilia ^a   Fernández Seara, María J ^b   Pérez Muñuzuri, Alejandro ^b   Lago, Ramón ^a   García Magán, Carlos ^b   Couce, María L ^b   Sobrino, Beatriz ^c   Amigo, Jorge ^c   Carracedo, Angel ^a,c,d   Barros, Francisco ^a,c  

^a Fundacion Publica Galega de Medicina Xenomica   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN C; STOP CODON; VEGFC PROTEIN, HUMAN;

ARTICLE; CASE REPORT; CELLULITIS; EXOME; FEMALE; FRAMESHIFT MUTATION; GENETIC ASSOCIATION; HUMAN; HYDROCELE; LYMPHEDEMA; MALE; MILROY DISEASE; MILROY LIKE DISEASE; NEWBORN; PHENOTYPE; PRIORITY JOURNAL; RARE DISEASE; GENETIC PREDISPOSITION; GENETICS; INFANT; PEDIGREE; STOP CODON;

CODON, TERMINATOR; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; LYMPHEDEMA; PEDIGREE; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84902551883     PISSN: 00222593     EISSN: 14686244     Source Type: Journal    
DOI: 10.1136/jmedgenet-2013-102020corr1     Document Type: Erratum

References (11)

1. Gordon K, Spiden SL, Connell FC, Brice G, Cottrell S, Short J, Taylor R, Jeffery S, Mortimer PS, Mansour S, Ostergaard P. FLT4/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update. Hum Mutat 2013;34:23-31.
2. Connell FC, Gordon K, Brice G, Keeley V, Jeffery S, Mortimer P, Mansour S, Ostergaard P. The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings. Clin Genet 2013;84:303-14.
3. Mellor RH, Hubert CE, Stanton AW, Tate N, Akhras V, Smith A, Burnand KG, Jeffery S, Mäkinen T, Levick JR, Mortimer PS. Lymphatic dysfunction, not aplasia, underlies Milroy disease. Microcirculation 2010;17:281-96.
4. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2004;5:74-80.
5. Baldwin ME, Halford MM, Roufail S, Williams RA, Hibbs ML, Grail D, Kubo H, Stacker SA, Achen MG. Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol Cell Biol 2005;25:2441-9.
6. Connell FC, Ostergaard P, Carver C, Brice G, Williams N, Mansour S, Mortimer PS, Jeffery S, Lymphoedema C. Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas. Hum Genet 2009;124:625-31.
7. Gordon K, Schulte D, Brice G, Simpson MA, Roukens MG, van Impel A, Connell F, Kalidas K, Jeffery S, Mortimer PS, Mansour S, Schulte-Merker S, Ostergaard P. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema. Circ Res 2013;112:956-60.
8. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010;20:1297-303.
9. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010;38:e164.
10. Zheng W, Tammela T, Yamamoto M, Anisimov A, Holopainen T, Kaijalainen S, Karpanen T, Lehti K, Yla-Herttuala S, Alitalo K. Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor. Blood 2011;118: 1154-62.
11. Olofsson B, Jeltsch M, Eriksson U, Alitalo K. Current biology of VEGF-B and VEGF-C. Curr Opin Biotechnol 1999;10:528-35.